Avecho Biotechnology Ltd has released a press release.
Avecho raises further $6M for Phase III trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Voluntary Suspension
- June 2023 Quarterly Activities Report & Appendix 4C
- AVE CBD capsule passes two-year stability milestone
- AVE adds TPM cannabinoid gummies to portfolio
- USPTO allows new TPM manufacturing patent
Later from Avecho Biotechnology
- Reinstatement to Official Quotation
- September 2023 Quarterly Activities Report & Appendix 4C
- December 2023 Quarterly Activities Report & Appendix 4C
- Appendix 4E and Annual Report 31 December 2023
- AVE receives final ethics approval for Phase III CBD trial
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology